- Home
- CEVA vs ABUS Comparison
CEVA vs ABUS Comparison
Compare CEVA & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEVA
- ABUS
- Stock Information
- Founded
- CEVA 1999
- ABUS 2005
- Country
- CEVA United States
- ABUS United States
- Employees
- CEVA N/A
- ABUS N/A
- Industry
- CEVA Semiconductors
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- CEVA Technology
- ABUS Health Care
- Exchange
- CEVA Nasdaq
- ABUS Nasdaq
- Market Cap
- CEVA 558.8M
- ABUS 592.8M
- IPO Year
- CEVA 2000
- ABUS N/A
- Fundamental
- Price
- CEVA $22.97
- ABUS $3.15
- Analyst Decision
- CEVA Strong Buy
- ABUS Strong Buy
- Analyst Count
- CEVA 5
- ABUS 4
- Target Price
- CEVA $38.60
- ABUS $5.50
- AVG Volume (30 Days)
- CEVA 258.1K
- ABUS 1.3M
- Earning Date
- CEVA 05-07-2025
- ABUS 05-01-2025
- Dividend Yield
- CEVA N/A
- ABUS N/A
- EPS Growth
- CEVA N/A
- ABUS N/A
- EPS
- CEVA N/A
- ABUS N/A
- Revenue
- CEVA $106,939,000.00
- ABUS $6,171,000.00
- Revenue This Year
- CEVA $11.13
- ABUS $14.57
- Revenue Next Year
- CEVA $13.14
- ABUS $15.84
- P/E Ratio
- CEVA N/A
- ABUS N/A
- Revenue Growth
- CEVA 9.77
- ABUS N/A
- 52 Week Low
- CEVA $16.02
- ABUS $2.63
- 52 Week High
- CEVA $38.94
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- CEVA 39.14
- ABUS 46.31
- Support Level
- CEVA $21.95
- ABUS $2.71
- Resistance Level
- CEVA $24.10
- ABUS $3.34
- Average True Range (ATR)
- CEVA 1.77
- ABUS 0.22
- MACD
- CEVA 0.17
- ABUS -0.01
- Stochastic Oscillator
- CEVA 49.73
- ABUS 48.89
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.